Vesa Juvonen
 


vesjuv@utu.fi

Publications
  • The KMT2A recombinome of acute leukemias in 2023  (2023)  
    • Leukemia
     Meyer C, Larghero P, Almeida Lopes B, Burmeister T, Gröger D, Sutton R, Venn NC, Cazzaniga G, Corral Abascal L, Tsaur G, Fechina L, Emerenciano M, Pombo-de-Oliveira MS, Lund-Aho T, Lundán T, Montonen M, Juvonen V, Zuna J, Trka J, Ballerini P, Lapillonne H, Van der Velden VHJ, Sonneveld E, Delabesse E, de Matos RRC, Silva MLM, Bomken S, Katsibardi K, Keernik M, Grardel N, Mason J, Price R, Kim J, Eckert C, Lo Nigro L, Bueno C, Menendez P, Zur Stadt U, Gameiro P, Sedék L, Szczepański T, Bidet A, Marcu V, Shichrur K, Izraeli S, Madsen HO, Schäfer BW, Kubetzko S, Kim R, Clappier E, Trautmann H, Brüggemann M, Archer P, Hancock J, Alten J, Möricke A, Stanulla M, Lentes J, Bergmann AK, Strehl S, Köhrer S, Nebral K, Dworzak MN, Haas OA, Arfeuille C, Caye-Eude A, Cavé H, Marschalek R
    (    A1 Refereed original research article in a scientific journal)


  • B-cell receptor stereotyped subsets and outcome for patients with chronic lymphocytic leukemia in the HOVON 68 trial  (2021)  
    • Journal of Translational Genetics and Genomics
     Vojdeman F.J., Pedersen L.B., Te Raa D., Juvonen V., van Norden Y., Tjønnfjord G.E., Kimby E., Itälä-Remes M., Rosenquist R., Langerak A.W., Evers L.M., Zenz T., Walewski J., van Oers M.H.J., Geisler C.H., Kater A.P., Niemann C.U.
    (    A1 Refereed original research article in a scientific journal)


  • Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting  (2020)  
    • Leukemia
     S. Modvig, H. Hallböök, H. O. Madsen, S. Siitonen, S. Rosthøj, A. Tierens, V. Juvonen, L. T. N. Osnes, H. Vålerhaugen, M. Hultdin, R. Matuzeviciene, M. Stoskus, M. Marincevic, A. Lilleorg, M. Ehinger, U. Norén-Nystrøm, N. Toft, M. Taskinen, O. G. Jónsson, K. Pruunsild, G. Vaitkeviciene, K. Vettenranta, B. Lund, J. Abrahamsson, A. Porwit, K. Schmiegelow, H. V. Marquart
    (    A1 Refereed original research article in a scientific journal)


  • Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions  (2019)  
    • Leukemia
     Claus Meyer, Bruno A. Lopes, Aurélie Caye-Eude, Hélène Cavé, Chloé Arfeuille, Wendy Cuccuini, Rosemary Sutton, Nicola C. Venn, Seung Hwan Oh, Grigory Tsaur, Gabriele Escherich, Tobias Feuchtinger, Hansen J. Kosasih, Seong L. Khaw, Paul G. Ekert, Maria S. Pombo-de-Oliveira, Audrey Bidet, Bardya Djahanschiri, Ingo Ebersberger, Marketa Zaliova, Jan Zuna, Zuzana Zermanova, Vesa Juvonen, Renate Panzer Grümayer, Grazia Fazio, Gianni Cazzaniga,
    Patrizia Larghero, Mariana Emerenciano, Rolf Marschalek
    (    B1 Non-refereed article in a scientific journal)


  • Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia  (2019)  
    • Leukemia
     S. Modvig, H. O. Madsen, S. M. Siitonen, S. Rosthøj, A. Tierens, V. Juvonen, L.T.N. Osnes, H. Vålerhaugen, M. Hultdin, I. Thörn, R. Matuzeviciene, M. Stoskus, M. Marincevic, L. Fogelstrand, A. Lilleorg, N. Toft, O. G. Jónsson, K. Pruunsild, G. Vaitkeviciene, K. Vettenranta, B. Lund, J. Abrahamsson, K. Schmiegelow, H. V. Marquart
    (    A1 Refereed original research article in a scientific journal)


  • The MLL recombinome of acute leukemias in 2017  (2018)  
    • Leukemia
     C Meyer, T Burmeister, D Gröger, G Tsaur, L Fechina, A Renneville, R Sutton, N C Venn, M Emerenciano, M S Pombo-de-Oliveira, C Barbieri Blunck, B Almeida Lopes, J Zuna, J Trka, P Ballerini, H Lapillonne, M De Braekeleer, G Cazzaniga, L Corral Abascal, V H J van der Velden, E Delabesse, T S Park, S H Oh, M L M Silva, T Lund-Aho, V Juvonen, A S Moore, O Heidenreich, J Vormoor, E Zerkalenkova, Y Olshanskaya, C Bueno, P Menendez, A Teigler-Schlegel, U zur Stadt, J Lentes, G Göhring, A Kustanovich, O Aleinikova, B W Schäfer, S Kubetzko, H O Madsen, B Gruhn, X Duarte, P Gameiro, E Lippert, A Bidet, J M Cayuela, E Clappier, C N Alonso, C M Zwaan, M M van den Heuvel-Eibrink, S Izraeli, L Trakhtenbrot, P Archer, J Hancock, A Möricke, J Alten, M Schrappe, M Stanulla, S Strehl, A Attarbaschi, M Dworzak, O A Haas, R Panzer-Grümayer, L Sedék, T Szczepański, A Caye, L Suarez, H Cavé, R Marschalek
    (    A1 Refereed original research article in a scientific journal)


  • Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro  (2016)  
    • Leukemia and Lymphoma
     Asadi-Azarbaijani B, Sheikhi M, Nurmio M, Tinkanen H, Juvonen V, Dunkel L, Hovatta O, Oskam IC, Jahnukainen K
    (    A1 Refereed original research article in a scientific journal)


  • Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma  (2014)  
    • Blood Cancer Journal
     R Silvennoinen, T Lundan, V Kairisto, T-T Pelliniemi, M Putkonen, P Anttila, V Huotari, P Mäntymaa, S Siitonen, L Uotila, T-L Penttilä, V Juvonen, T Selander, K Remes
    (    A1 Refereed original research article in a scientific journal)


  • Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients  (2013)  
    • British Journal of Haematology
     Silvennoinen R, Kairisto V, Pelliniemi TT, Putkonen M, Anttila P, Saily M, Sikio A, Opas J, Penttila K, Kuittinen T, Honkanen T, Lundan T, Juvonen V, Luukkaala T, Remes K
    (    B1 Non-refereed article in a scientific journal)


  • Bone marrow remission status predicts leukemia contamination in ovarian biopsies collected for fertility preservation  (2013)  
    • Leukemia
     Jahnukainen K, Tinkanen H, Wikstrom A, Dunkel L, Saarinen-Pihkala UM, Makinen S, Azarbaijani BA, Oskam IC, Vettenranta K, Laine T, Kairisto V, Juvonen V
    (    B1 Non-refereed article in a scientific journal)


  • The MLL recombinome of acute leukemias in 2013  (2013)  
    • Leukemia
     Meyer C, Hofmann J, Burmeister T, Groger D, Park TS, Emerenciano M, de Oliveira MP, Renneville A, Villarese P, Macintyre E, Cave H, Clappier E, Mass-Malo K, Zuna J, Trka J, De Braekeleer E, De Braekeleer M, Oh SH, Tsaur G, Fechina L, van der Velden VHJ, van Dongen JJM, Delabesse E, Binato R, Silva MLM, Kustanovich A, Aleinikova O, Harris MH, Lund-Aho T, Juvonen V, Heidenreich O, Vormoor J, Choi WWL, Jarosova M, Kolenova A, Bueno C, Menendez P, Wehner S, Eckert C, Talmant P, Tondeur S, Lippert E, Launay E, Henry C, Ballerini P, Lapillone H, Callanan MB, Cayuela JM, Herbaux C, Cazzaniga G, Kakadiya PM, Bohlander S, Ahlmann M, Choi JR, Gameiro P, Lee DS, Krauter J, Cornillet-Lefebvre P, Kronnie GT, Schafer BW, Kubetzko S, Alonso CN, Stadt UZ, Sutton R, Venn NC, Izraeli S, Trakhtenbrot L, Madsen HO, Archer P, Hancock J, Cerveira N, Teixeira MR, Lo Nigro L, Moricke A, Stanulla M, Schrappe M, Sedek L, Szczepanski T, Zwaan CM, Coenen EA, van den Heuvel-Eibrink MM, Strehl S, Dworzak M, Panzer-Grumayer R, Dingermann T, Klingebiel T, Marschalek R
    (    A1 Refereed original research article in a scientific journal)


  • Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy  (2010)  
    • Blood
     Kreutzman A, Juvonen V, Kairisto V, Ekblom M, Stenke L, Seggewiss R, Porkka K, Mustjoki S
    (    A1 Refereed original research article in a scientific journal)



Last updated on 2023-12-07 at 11:58